Literature DB >> 26412310

The prognostic factors and trajectory of HRQOL in patients with pancreatic cancer who received psychiatric intervention.

Hiroyuki Sugimoto1, Hiroki Kawashima1, Eizaburo Ohno1, Daijuro Hayashi1, Takamichi Kuwahara1, Tomomasa Morishima1, Manabu Kawai1, Hiroki Suhara1, Tomoaki Takeyama1, Takeshi Yamamura2, Kohei Funasaka1, Masanao Nakamura1, Ryoji Miyahara1, Osamu Watanabe1, Masatoshi Ishigami1, Miho Suzuki3, Hiroyuki Kimura3, Norio Ozaki3, Senju Hashimoto4, Hidemi Goto1, Yoshiki Hirooka2.   

Abstract

BACKGROUND AND AIM: Patients with advanced pancreatic cancer have severe pain, anxiety, and depression, and these symptoms deteriorate quality of life (QOL). Previous study reported that early psychiatric intervention for advanced cancer patients may improve QOL. We evaluated the trajectory of health-related QOL (HRQOL) in patients with pancreatic cancer after an early psychiatric intervention.
METHODS: A prospective cohort study was performed in 108 pancreatic cancer patients who received consultation liaison psychiatry from November, 2011 to October, 2014 at Nagoya University Hospital. Longitudinal changes in HRQOL and the association between aspects of HRQOL and survival were evaluated using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire core 30 before treatment and every month after the start of treatment.
RESULTS: Physical functioning significantly decreased after 1, 3, and 6 months of treatment compared with baseline, but global health status (GHS), role functioning, emotional functioning, and social functioning showed a tendency to improve. Severe impairment of GHS, fatigue, and appetite loss were apparent at 3 months prior to death. In multivariate analysis, pain was a significant prognostic factor for survival (hazard ratio [HR], 1.109; 95% confidence interval [CI], 1.021-1.204; P = 0.013), in addition to poor performance status (HR, 5.473; 95%CI, 2.338-12.816; P < .0001) and distant metastases at diagnosis (HR, 3.274; 95%CI, 1.872-5.725; P < .0001).
CONCLUSIONS: Early psychiatric intervention in patients with pancreatic cancer may maintain HRQOL. More effective pain management and reduction of psychological distress are important for patients with pancreatic cancer.
© 2015 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  EORTC QLQ-C30; HRQOL; pancreatic cancer; psychiatric intervention; psychological distress

Mesh:

Year:  2016        PMID: 26412310     DOI: 10.1111/jgh.13172

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  β2-adrenergic receptor drives the metastasis and invasion of pancreatic ductal adenocarcinoma through activating Cdc42 signaling pathway.

Authors:  Chen Gong; Baoying Hu; Haifeng Chen; Jianxin Zhu; Jinshan Nie; Lu Hua; Long Chen; Yanfei Fang; Cheng Hang; Ye Lu
Journal:  J Mol Histol       Date:  2022-06-18       Impact factor: 3.156

2.  Health-related quality of life and medical comorbidities in older patients with pancreatic adenocarcinoma: An analysis using the 1998-2011 surveillance, epidemiology, and end results-medicare health outcomes survey data.

Authors:  Shan S Wong; Fang-Chi Hsu; Nancy E Avis; Clancy J Clark
Journal:  J Geriatr Oncol       Date:  2019-09-09       Impact factor: 3.929

3.  Exploring the patient experience of locally advanced or metastatic pancreatic cancer to inform patient-reported outcomes assessment.

Authors:  Joseph M Herman; Helen Kitchen; Arnold Degboe; Natalie V J Aldhouse; Andrew Trigg; Mary Hodgin; Amol Narang; Colin D Johnson
Journal:  Qual Life Res       Date:  2019-07-04       Impact factor: 4.147

4.  Experiences and supportive care needs of UK patients with pancreatic cancer: a cross-sectional questionnaire survey.

Authors:  Eila K Watson; Jo Brett; Harriet Hay; Cara Witwicki; Anna Perris; Alan J Poots; Steve Sizmur; Zahir Soonawalla; Amy Tallett
Journal:  BMJ Open       Date:  2019-11-04       Impact factor: 2.692

5.  Quality of life of patients with metastatic pancreatic adenocarcinoma initiating first-line chemotherapy in routine practice.

Authors:  Berta Laquente; Teresa Macarulla; Cristina Bugés; Marta Martín; Carlos García; Carles Pericay; Sandra Merino; Laura Visa; Teresa Martín; Manuela Pedraza; Beatriz Carnero; Raquel Guardeño; Helena Verdaguer; Alejandro Mut; David Vilanova; Adelaida García
Journal:  BMC Palliat Care       Date:  2020-07-10       Impact factor: 3.234

6.  Association between chronological depressive changes and physical symptoms in postoperative pancreatic cancer patients.

Authors:  Naoko Sato; Yoshimi Hasegawa; Asami Saito; Fuyuhiko Motoi; Kyohei Ariake; Yu Katayose; Kei Nakagawa; Kei Kawaguchi; Shin Fukudo; Michiaki Unno; Fumiko Sato
Journal:  Biopsychosoc Med       Date:  2018-09-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.